Story perspectives

Breakthrough Immunotherapy Targets Slow-Growing Bowel Cancer Cells

10/18/2025

Summary

Story summary

Researchers at University College London (UCL) have engineered ??T cells to target slow-growing bowel cancer cells.
The modified ??T cells use a dual mechanism of action to enhance their ability to eliminate cancer cells.
UCL's advanced 'phenoscaping' technology provided insights into interactions within tumor-immune ecosystems, guiding further improvements.
The research, supported by major organizations, represents a potential breakthrough in developing effective immunotherapies for bowel cancer and other solid tumors.

1 of 1

Story summary

Researchers at University College London (UCL) have engineered ??T cells to target slow-growing bowel cancer cells.
The modified ??T cells use a dual mechanism of action to enhance their ability to eliminate cancer cells.
UCL's advanced 'phenoscaping' technology provided insights into interactions within tumor-immune ecosystems, guiding further improvements.
The research, supported by major organizations, represents a potential breakthrough in developing effective immunotherapies for bowel cancer and other solid tumors.